Geode Capital Management, LLC Oric Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,222,692 shares of ORIC stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,222,692

Previous 911,633 34.12%

Holding current value

$12.6 Million

Previous $12.5 Million 31.04%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$6.63 - $12.93 $2.06 Million - $4.02 Million	311,059 Added 34.12%	1,222,692 $8.64 Million
Q1 2024 May 13, 2024	BUY	$8.04 - $16.03 $295,405 - $588,974	36,742 Added 4.2%	911,633 $12.5 Million
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $294,542 - $513,406	54,444 Added 6.64%	874,891 $8.05 Million
Q3 2023 Nov 13, 2023	BUY	$6.05 - $9.28 $550,943 - $845,083	91,065 Added 12.49%	820,447 $4.96 Million
Q2 2023 Aug 11, 2023	BUY	$4.95 - $8.4 $2.09 Million - $3.54 Million	421,960 Added 137.26%	729,382 $5.66 Million
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $101,008 - $160,049	23,711 Added 8.36%	307,422 $1.75 Million
Q4 2022 Feb 13, 2023	SELL	$2.41 - $5.89 $1,438 - $3,516	-597 Reduced 0.21%	283,711 $1.67 Million
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $126,204 - $209,940	-40,065 Reduced 12.35%	284,308 $909,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.07 $687,012 - $1.8 Million	-254,449 Reduced 43.96%	324,373 $1.45 Million
Q1 2022 May 13, 2022	SELL	$4.54 - $16.1 $168,207 - $596,505	-37,050 Reduced 6.02%	578,822 $3.09 Million
Q4 2021 Feb 11, 2022	SELL	$12.01 - $20.3 $424,577 - $717,645	-35,352 Reduced 5.43%	615,872 $9.05 Million
Q3 2021 Nov 12, 2021	BUY	$15.9 - $25.22 $3.87 Million - $6.14 Million	243,343 Added 59.66%	651,224 $13.6 Million
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $1.24 Million - $1.81 Million	71,418 Added 21.23%	407,881 $7.22 Million
Q1 2021 May 12, 2021	BUY	$23.67 - $36.85 $519,864 - $809,336	21,963 Added 6.98%	336,463 $8.24 Million
Q4 2020 Feb 12, 2021	BUY	$20.32 - $39.8 $3.55 Million - $6.96 Million	174,895 Added 125.28%	314,500 $10.6 Million
Q3 2020 Nov 13, 2020	BUY	$19.5 - $31.26 $28,840 - $46,233	1,479 Added 1.07%	139,605 $3.49 Million
Q2 2020 Aug 13, 2020	BUY	$25.68 - $38.12 $3.55 Million - $5.27 Million	138,126 New	138,126 $4.66 Million

Others Institutions Holding ORIC

# of Institutions

116

Shares Held

63.1M

Call Options Held

Put Options Held

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $408M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Oric Pharmaceuticals, Inc. Transaction History